By constructing nanocarriers, active ingredients can be protected from damage in the digestive tract environment, reducing toxicity and increasing their absorption rate in the gastrointestinal tract, thus significantly improving bioavailability
Size: 120 Capsules
This, in turn, supports DNA repair processes and reduces neuroinflammation, potentially improving cognitive function and slowing the progression of neurodegenerative conditions
Hondo M, Furutani N, Yamasaki M, Watanabe M, Sakurai T
[DOI] [PubMed] [Google Scholar] 85.Robinson B.L., Dumas M., Cuevas E., Gu Q., Paule M.G., Ali S.F., Kanungo J
FDA Safety Concerns The FDAs current compounding information states that BPC-157 may present immunogenicity risks for certain routes and raises challenges involving peptide impurities and active-ingredient characterisation